Cyclophosphamide and bladder cancer
Hem, E.; Jakobsen, A.; Urnes, T.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 104(1): 24-26
1984
ISSN/ISBN: 0029-2001 PMID: 6695365 Document Number: 241218
Document emailed within 1 workday
Related Documents
Del Zingaro, M.; Bruno, R.; Nunzi, E.; Porena, M.; Mearini, L. 2016: First and second transurethral resections in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer Minerva Urologica e Nefrologica 68(2): 194-203Wetzel, V.; Schaumlöffel, E. 1976: Isoelectric focusing of an alkylating 3H-cyclophosphamide derivative from human bladder urine International Journal of Clinical Pharmacology and Biopharmacy 14(4): 279-283
Hacker, M.P.; Ershler, W.B.; Newman, R.A.; Fagan, M.A. 1983: Chronobiologic fluctuation of cyclophosphamide induced urinary bladder damage in mice Chronobiologia 10(3): 301-306
Juszczak, K.; Królczyk, G.; Filipek, M.; Dobrowolski, Z.F.; Thor, P.J. 2007: Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats Folia Medica Cracoviensia 48(1-4): 113-123
Gad-el-Mawla, N.; Ziegler, J.L.; Hamza, R.; Elserafi, M.; Khaled, H. 1984: Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder Cancer Treatment Reports 68(2): 419-421
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Mommsen, S.; Jakobsen, A.; Sell, A. 1989: Quality of life in patients with advanced bladder cancer. a randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scandinavian Journal of Urology and Nephrology. Supplementum 125: 115-120
Aihara, R.; Sato, K.; Sasaki, K.; Hosaka, Y.; Narita, T. 1985: Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis Nursing Technique 31(11): 1492-1497
Bellin, H.J.; Cherry, J.M.; Koss, L.G. 1974: Effects of a single dose of cyclophosphamide. V. Protective effect of diversion of the urinary stream on dog bladder Laboratory Investigation; a Journal of Technical Methods and Pathology 30(1): 43-47
Yoshida, M.; Numoto, S.; Otsuka, H. 1979: Histopathological changes induced in the urinary bladder and liver of female BALB/c mice treated simultaneously with 2-naph-thylamine and cyclophosphamide Gan 70(5): 645-652
Miyazaki, J. 2018: IIi .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 33-37
Ericson, K.J.; Murthy, P.B.; Bryk, D.J.; Ramkumar, R.R.; Broughman, J.R.; Khanna, A.; Mian, O.Y.; Campbell, S.C. 2019: Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer Clinical Advances in Hematology and Oncology: H&o 17(12): 697-707
Held, J.; Volpe, H. 1991: Bladder preserving combined modality therapy for invasive bladder cancer Oncology Nursing Forum 18(1): 49-57
Sekita, N.; Egoshi, K.; Hamano, S.; Matsuzaki, O. 2006: Ileovesical fistula caused by bladder cancer with bladder stone Hinyokika Kiyo. Acta Urologica Japonica 52(10): 793-796
Koss, L.G.; Lavin, P. 1971: Studies of experimental bladder carcinoma in Fischer 344 female rats. I. Induction of tumors with diet low in vitamin B6 containing N-2-fluorenylacetamide after single dose of cyclophosphamide Journal of the National Cancer Institute 46(3): 585-595
Trifard, F.; Chrétien, Y.; Vallantin, X.; Collet, C.; Lachand, A.T.; Dufour, B. 1988: [Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients Annales d'Urologie 22(3): 216-219
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Flanagan, M.J.; Ekbal, S.; Coogan, P.S.; Kalin, G.; Hass, G.M. 1975: Tryptophan urinary bladder absorption and bladder cancer Investigative Urology 13(1): 17-19
Fitzpatrick, R.; Paterson, N.R.; Belanger, E.C.; McCurdy, A.; Watterson, J. 2017: Primary amyloidosis of the bladder; a mimicker of bladder cancer Canadian Journal of Urology 24(3): 8868-8870
Fukui, Y.; Samma, S.; Fujimoto, K.; Akiyama, T.; Yamaguchi, A.; Hirayama, A. 2001: Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations Hinyokika Kiyo. Acta Urologica Japonica 47(5): 311-314